Generex Subsidiary Antigen Express Provides Update On Phase 2 Breast Cancer Immunothe
Generex Biotechnology Corporation (OTCBB: GNBT) announced that the Company's wholly-owned subsidiary Antigen Express, Inc...
More... |
All times are GMT -7. The time now is 07:54 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021